HEALTH ECONOMICS AND POLICY ADVISORY
Established in 2021, Zeumed is a health economics and policy consulting company specialising in advising governments and payers.
Our expertise includes health financing reform, econometric modelling, cost-benefit analysis, health investment opportunities, and health policy evaluation.
Zeumed translates complex economic concepts into actionable insights for decision-makers in healthcare through a structured and targeted approach. Our services include:
Health Economic
Analysis
Conducting robustness testing of health economic submissions, including value-based payment models, designed for both providers and payers.
Digital Health
Alignment
Reviewing digital health tenders to ensure alignment with payer priorities and value delivery.
Strategic Health
Financing
Offering expert advice on financing models, population-level budgetary planning, and the development of governance frameworks to enhance strategic purchasing for primary, secondary, and tertiary care.
Market Entry
Strategies
Formulating market entry plans for medtech and medical device companies, integrating national reimbursement strategies into their approach.
Indicator Development and Negotiation Support
Identifying key performance indicators for payment models and supporting negotiations with the life sciences
industry.
Investment
Reviews
Providing clinical and economic evaluations of healthcare and life science investment opportunities to guide impactful decision-making.
We work with
.png){kind=small}
National health care payers
Governments and Ministries of Health (for both emerging and developed economies)
Insurers and reinsurers
NGOs in the health sector
Entrepreneurs involved in bringing medical technology or devices to market
Health sector and life science investors
Available Services
Founder and CEO
Dr Fiona Kiernan
Zeumed was established to address some of healthcare’s most pressing challenges. As a former senior doctor with 17 years of clinical experience and a PhD in Economics, I’ve always been driven by the intersection of health and economics—how policy, funding, and innovation come together to shape the care people receive.
My career has taken me across Ireland, the United Kingdom, France, Germany, and Switzerland, working in diverse healthcare systems and markets. Alongside my deep academic expertise, I bring significant commercial acumen, having advised global healthcare payers, life sciences companies, and ministries of health on pragmatic, real-world solutions to complex problems. This balance of academic rigor and commercial insight ensures that my recommendations are both evidence-based and actionable. My work has been featured in peer-reviewed journals, health industry magazines, industry podcasts, and national media.
